Obesity, Metabolic Syndrome and the Risk of Microvascular Complications in Patients with Diabetes mellitus.
Τίτλος | Obesity, Metabolic Syndrome and the Risk of Microvascular Complications in Patients with Diabetes mellitus. |
Publication Type | Journal Article |
Year of Publication | 2019 |
Authors | Katsiki, N., Anagnostis P., Kotsa K., Goulis D. G., & Mikhailidis D. P. |
Journal | Curr Pharm Des |
Volume | 25 |
Issue | 18 |
Pagination | 2051-2059 |
Date Published | 2019 |
ISSN | 1873-4286 |
Λέξεις κλειδιά | Cardiovascular Diseases, Diabetes Mellitus, Type 2, Humans, Metabolic syndrome, Non-alcoholic Fatty Liver Disease, Obesity, Risk Factors |
Abstract | BACKGROUND: Obesity frequently co-exists with type 2 diabetes mellitus (T2DM), leading to the socalled "diabesity epidemic". The metabolic syndrome (MetS), a cluster of central obesity, hypertension, dysglycemia, insulin resistance and/or atherogenic dyslipidemia, as well as non-alcoholic fatty liver disease (NAFLD), a hepatic manifestation of MetS, has been associated with increased cardiovascular disease (CVD), T2DM and chronic kidney disease (CKD) incidence. However, the association between obesity, MetS (including NAFLD) and diabetic microvascular complications is less evident. |
DOI | 10.2174/1381612825666190708192134 |
Alternate Journal | Curr Pharm Des |
PubMed ID | 31298151 |